Apurba's CEO gives a talk at ASAIO 66th Annual Conference in Washington DC
Apurba's CEO gives a talk at ASAIO 66th Annual Conference in Washington DC
Added on 13th June 2021
June 10th, 2021 – Apurba's CEO gives a talk title “COVID-19 Big Data and AI – Utility in Pandemics and Public Health – Hope vs. Hype” at ASAIO 66th Annual Conference in Washington DC. This conference is organized by ASAIO on 10th - 12th June 2020 at Hilton DC Hotel, Washington DC.
The presentation shows a case study demonstrating that it was possible, with a high degree of accuracy, to predict the onset of influenza using the NLP-based population health analytics approach, and given that the concept produced positive results for one respiratory virus, it stands to reason that a similar approach ought to be practical for other similar illnesses, notably COVID-19.
ASAIO is formerly known as the American Society for Artificial Internal Organs. ASAIO's mission is to provide a forum that globally and collaboratively promotes the development of innovative medical device technology at the crossroads of science, engineering, and medicine. At the ASAIO Annual Conference 2021, the participants will be able to discuss current needs for medical device research and development, and the steps needed for successful development from concept to translation into clinical practices and adult populations. For more information about the event, please visit the website ASAIO Annual Conference 2021.
Apurba Technologies Inc. is a Sunnyvale, CA, based software development company that creates enterprise big data solutions using natural language processing, machine learning and artificial intelligence — primarily for the healthcare, financial and automotive sectors.
